February 25, 2021 — Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) cardiologist Dinesh Thavendiranathan, M.D., point to the benefit of using a more sensitive cardiac ultrasound test to detect cardiotoxicity heart function issues early, so cancer patients do not have to fight

February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024, finds that the MRI market is diversifying with momentum in the privatization trend. Growing public-private partnerships and an increase in near-replacement time in public domains are expected to attract more MRI system procurements.

February 24, 2021 — An open-access article in ARRS’ American Journal of Roentgenology (AJR) describes the clinical and imaging features of axillary adenopathy detected during screening or diagnostic brea

February 24, 2021 — Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations). The acquisition brings an expert team of Ph.D.

February 23, 2021 — Hologic, Inc. has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.

February 23, 2021 — A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.

February 23, 2021 — icometrix, world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio.

February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy.

February 22, 2021 — A new X-ray imaging scanner to help surgeons performing breast tumor removal surgery has been developed by UCL experts.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now